ASSENT 3 PLUS

(redirected from Assessment of the Safety of a New Thrombolytic-3 Plus)

ASSENT 3 PLUS

Assessment of the Safety of a New Thrombolytic-3 Plus. A clinical trial comparing enoxaparin and unfractionated heparin in prehospital management of acute myocardial infarction; ASSENT 3 PLUS failed to meet its primary outcome.
Full browser ?